Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorCarcak, Nihan
dc.contributor.authorSahiner, Melike
dc.contributor.authorAkman, Ozlem
dc.contributor.authorIdrizoglu, Medine Gulcebi
dc.contributor.authorCortez, Miguel A.
dc.contributor.authorSnead, O. Carter
dc.contributor.authorOnat, Filiz
dc.date.accessioned2020-12-02T18:01:39Z
dc.date.available2020-12-02T18:01:39Z
dc.date.issued2020
dc.identifier.issn2148-4902
dc.identifier.urihttps://doi.org/10.14744/nci.2019.80664
dc.identifier.urihttp://hdl.handle.net/11446/3684
dc.descriptionWOS: 000514812200005en_US
dc.descriptionPubMed: 32232200en_US
dc.description.abstractOBJECTIVE: This study aimed to investigate the effects of gamma-butyrolactone (GBL), a prodrug of gamma-Hydroxybutyric acid-induced absence seizures on the development of kindling in Wistar rats. METHODS: Three groups of adult male Wistar rats under anesthesia were implanted with bilateral cortical recording elec- trodes for the GBL group (GBL) and/or bipolar stimulation electrodes into the right basolateral amygdala for the Kindling group (KI) alone and Kindling plus GBL group (GBL+KI). Rats in the KI and GBL+KI groups were stimulated twice daily at the afterdischarge threshold until they reached Racine's stage 5 seizure state. the animals in the GBL + group had an i.p injection of GBL 20 minutes before each electrical stimulation, and the effects of GBL-induced seizures on the development of kindling were investigated. the animals in the GBL group were injected GBL twice daily i.p. for 15 days without receiving any electrical stimulation. RESULTS: the KI animals reached stage 5 seizure stage at 12th stimulations, whereas the GBL+KI rats reached at 27th stimulations. the mean numbers of stimulations needed for the development of the first stage 3, 4, or 5 generalized seizures were significantly higher in the GBL+KI group than the KI group. CONCLUSION: the resistance to amygdala kindling in the GBL model can be modulated by the absence seizure mechanism alone, without the intervention of an abnormal genetic background.en_US
dc.description.sponsorshipMarmara University Research Council (BAPKO)Marmara University [SAG-D-300409-0116]en_US
dc.description.sponsorshipThis study was supported by Marmara University Research Council (BAPKO, SAG-D-300409-0116).en_US
dc.language.isoengen_US
dc.publisherKare Publen_US
dc.identifier.doi10.14744/nci.2019.80664en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAmygdalaen_US
dc.subjectgamma-butyrolactoneen_US
dc.subjectexperimental limbic epilepsyen_US
dc.subjectgenetic absence epilepsyen_US
dc.subjectkindlingen_US
dc.titlePharmacologically induced absence seizures versus kindling in Wistar ratsen_US
dc.typearticleen_US
dc.relation.journalNorthern Clinics of Istanbulen_US
dc.departmentDBÜen_US
dc.identifier.issue1en_US
dc.identifier.volume7en_US
dc.identifier.startpage25en_US
dc.identifier.endpage34en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Carcak, Nihan] Istanbul Univ, Fac Pharm, Dept Pharmacol, Istanbul, Turkey; [Sahiner, Melike] Acibadem Mehmet Ali Aydinlar Univ, Fac Med, Dept Physiol, Istanbul, Turkey; [Akman, Ozlem] Istanbul Bilim Univ, Fac Med, Dept Physiol, Istanbul, Turkey; [Idrizoglu, Medine Gulcebi; Onat, Filiz] Marmara Univ, Fac Med, Dept Med Pharmacol, Istanbul, Turkey; [Cortez, Miguel A.; Snead, O. Carter] Univ Toronto, Fac Med, Dept Pediat Neurol, Toronto, ON, Canada; [Eskazan, Esat] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Med Pharmacol, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster